MEGIDDO DALIA enters NASUS PHARMA LTD with 1.89M shares across direct and indirect positions
This filing by MEGIDDO DALIA (Chief Development Officer) establishes the baseline for all future Form 4 insider transaction reports at NASUS PHARMA LTD.
Direct Indirect
Filed: 3/27/2026ACC: 0001493152-26-013386
DirectorOfficerOther· Chief Development Officer
Since Mar 2026
1.89M
Baseline shares
100% direct
1.89M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
2
Security positions
5.20K indirect
Non-Derivative Holdings2
Ordinary Shares
IndirectShares owned5.20K
Ordinary Shares
DirectShares owned1.89M
Total
1.89M direct·5.20K indirect1.89M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 5.20K | Indirect |
| Ordinary Shares | 1.89M | Direct |
| Total | 1.89M | 1.89M direct·5.20K indirect |
Derivative Holdings0
No derivative holdings reported